Infection and Pharmacology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/81

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:30 PM on 9/30/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

82 Terms

1
New cards

infection

presence and multiplication of a living organism on or within a host, inducing subsequent injury/disease to the host

2
New cards

host

organism capable of supporting the nutritional and physical growth requirements of another organism

3
New cards

infectious disease

disease state due to an infection that invades the host's body and has potential for harm or lethal consequences to the host

4
New cards

colonization

when a microorganism adheres to epithelial tissue surfaces and can reproduce/multiply in that environment

5
New cards

pathogen

microorganism displaying virulence towards a host, usually causing disease

6
New cards

infectivity

the ability of an organism to colonize a host

7
New cards

virulence

the degree to which an organism is pathogenic and able to infect a host

8
New cards

factors influencing virulence

adhesiveness, evasiveness, and invasiveness

9
New cards

how a symbiotic relationship can become an infection

when the microflora is ingested or contaminates an area it does not belong

10
New cards

chain of infection

pathogen, source/reservoir, transmission/port of entry, susceptible host

11
New cards

factors determining a pathogen's ability to overcome a host's defenses

number of pathogenic organisms transmitted, mode of transmission, stability of pathogen outside of host

12
New cards

prions

infectious proteins

13
New cards

viruses

Pieces of genetic material surrounded by a protein capsule

14
New cards

bacteria

single-celled organisms that lack a nucleus; prokaryotes

15
New cards

fungi

Eukaryotic organisms with chitin cell walls.

16
New cards

parasites

Organisms that grow, feed, and shelter on or in another organism

17
New cards

common symptoms of infection

fever, leukocytosis, lethargy, head/body aches

18
New cards

leukocytosis

higher WBC count

19
New cards

stages of infection

incubation, prodromal, acute, convalescent, resolution

20
New cards

pharmacology

science dealing with the effects of drugs on living organisms

21
New cards

toxicology

adverse effects of drugs on living organisms

22
New cards

pharmacotherapeutics

The treatment of pathologic conditions through the use of drugs

23
New cards

pharmacokinetics

how the body acts on the drug

24
New cards

pharmacodynamics

how the drug acts on the body

25
New cards

agent

any drug, biological product, or medical device

26
New cards

drug

any chemical that affects a biological system

27
New cards

medicine

drug used for the treatment or prevention of disease

28
New cards

pharmacologic tool

drug, biological product, natural substance, or other tool used in research to investigate system/tissue function or effects of drugs

29
New cards

stages of pharmacokinetics

absorption, distribution/storage, metabolism, excretion

30
New cards

factors that influence pharmacokinetics

medication errors, patient compliance, physiological/pathological/genetic variables, drug interactions

31
New cards

enteral absorption

absorption by way of moving through the GI tract

32
New cards

examples of enteral absorption

oral, sublingual, buccal, rectal

33
New cards

pros of enteral absorption

convenient

34
New cards

cons of enteral absorption

less predictable dosage, speed of effect, rish of widespread systemic exposure to drug

35
New cards

parenteral absorption

absorption by direct administration to area, bypassing GI tract

36
New cards

examples of parenteral absorption

injections, topical, transdermal, inhalation

37
New cards

pros of parenteral absorption

more predictable dosage reaching target tissue

38
New cards

cons of parenteral absorption

less convenient

39
New cards

pros of oral absorption

maximum convenience

40
New cards

cons of oral absorption

subject to first-pass metabolism, may cause GI irritation

41
New cards

pros of sublingual absorption

bypasses first-pass metabolism, rapid onset

42
New cards

cons of sublingual, buccal, and rectal absorption

drug biochemistry must fit, limited amount/rate of absorption, local irritation

43
New cards

pros of buccal absorption

bypasses first-pass metabolism

44
New cards

pros of rectal absorption

partial bypass of first-pass metabolism, good for when drugs cannot be given orally

45
New cards

first-pass metabolism

drug metabolism that occurs in the intestines and liver during oral absorption of drugs into the systemic circulation

46
New cards

pros of intravenous injection

instantaneous, maximal absorption

47
New cards

cons of intravenous injection

sterility concerns, crucial to get dose accuracy

48
New cards

pros of intramuscular injection

reservoir

49
New cards

cons of intramuscular injection

sterility concerns, local irritation

50
New cards

pros of subcutaneous injection

reservoir, can be given as a liquid or solid pellet

51
New cards

cons of subcutaneous injection

slowest acting injection, limited amount, sterility concerns, local irritation

52
New cards

pros of topical absorption

close delivery to target site, avoids first-pass

53
New cards

cons of topical and transdermal absorption

rate of absorption varies depending on site of application

54
New cards

pros of transdermal absorption

avoids first-pass metabolism

55
New cards

pros of inhalation absorption

close delivery to target site, avoids first-pass, rapid absorption

56
New cards

cons of inhalation absorption

irritation

57
New cards

bioavailability

percentage of active drug that reaches systemic circulation

58
New cards

factors affecting absorption

blood flow, surface area available, contact time, drug concentration

59
New cards

distribution

process by which a drug reversibly leaves the bloodstream and enters the tissue/cells

60
New cards

factors affecting distribution

size of target, blood flow, drug properties, binding/sequestering of drug, anatomic barriers

61
New cards

tissues that store drugs for the longest

fat and muscle

62
New cards

four types of drug metabolism

active to different active form, active to inactive, inactive to active, remains active until excretion

63
New cards

primary location of drug metabolism

liver

64
New cards

primary location of drug excretion

kidneys

65
New cards

clearance

amount of active drug removed from the blood over a given period of time

66
New cards

factors determining clearance

blood flow and organ's ability to extract the drug from the blood

67
New cards

steady state

point of equilibrium where the dose administered equals the amount eliminated

68
New cards

type I receptor

cell surface receptor

69
New cards

type II receptor

located within the cytoplasm

70
New cards

type III receptor

receptor located on the nucleus

71
New cards

drug selectivity

ability of a drug to interact with a specific receptor of target tissue and not with other receptors

72
New cards

affinity

an attraction to

73
New cards

efficacy

effectiveness

74
New cards

agonist drug action

high affinity for a receptor and high efficacy

75
New cards

antagonist drug action

high affinity for a receptor but no efficacy

76
New cards

quantal response

an all-or-none binary biological response

77
New cards

role of receptor occupancy

concept that the intensity of the drug action is related to the number of receptors occupied and the concentration of occupied receptors

78
New cards

threshold dose

lowest dose that produces a desired effect

79
New cards

ceiling dose

the dose above which no further beneficial drug effect will occur

80
New cards

potency

strength of a drug

81
New cards

therapeutic window

the concentration of a drug that has the desired effects without the toxicity/danger to the body

82
New cards

therapeutic index

the difference between the percentage of people having a toxic response and the percentage of people having a beneficial response to a drug